A novel approach to addressing age-related cognitive decline has been put forward by researchers affiliated with the Nareş K. Vasishta Medical College at Texas A&M University. Their findings were published in the Journal of Extracellular Vesicles.
The core of this development is a nasal spray formulation containing extracellular vesicles. These are minute particles engineered to act as carriers for microRNAs, which govern gene function and signaling cascades within the brain.
What distinguishes this technique is its delivery mechanism. It allows these particles to bypass the blood-brain barrier, granting them direct access to brain tissue. Once inside immune cells, the delivered microRNAs serve to suppress the NLRP3 inflammasome and the cGAS–STING pathways, both of which trigger persistent inflammation associated with aging. Simultaneously, this process aids in rejuvenating neuronal mitochondria, thereby restoring the cells’ capacity to process information by re-energizing them.
The results from the study indicated enhanced object recognition and a greater ability to detect environmental shifts in the test subjects. This beneficial outcome persisted for several months following the administration of just two doses. The study authors suggest that this therapeutic intervention stimulates the brain’s intrinsic self-repair mechanisms, leading to the resolution of inflammatory sites.
The treatment exhibits uniform efficacy across both male and female subjects. In the future, this method holds promise for use in human patients recovering from strokes or as a means to slow down the process of cognitive aging.
About the Author
